Testing Status of 3'-Azido-3'-deoxythymidine and 2',3'-Dideoxycytidine M890013
CASRN: AZTDDCCOMB
Related: AZT, DDC
Formula: C10-H13-N5-O4 C9-H13-N3-O3
Synonyms/Common Names
- 3'-Azido-3'-deoxythymidine/2',3'-Dideoxycytidine (AIDS initiative)
- AZT + DDC
Secondary:
- 30516-87-1 - 3'-Azido-3'-deoxythymidine (AIDS)
- 30516-87-1 - AZT transplacental carcinogenesis study
- 7481-89-2 - 2',3'-Dideoxycytidine
Short-Term Toxicity
- 4 weeks (Gavage)
(C89007)
Completed
- Mice: B6C3F1
- Dose: M: VARIOUS COMBINATIONS OF AZT 0, 500, OR 1000 MG/KG/DAY WITH DDC 0, 10, 100, 500, OR 1000 MG/KG/DAY.
Special Studies
- Toxicokinetic Study (Gavage)
(K89007)
Completed
- Single Dose Plasma Drug Concentration Study
- Male Mice: B6C3F1
- Dose: 500 AZT|0 ddC , 0 AZT|500 ddC, 500 AZT|10 ddC, 500 AZT|500 ddC, or 1000 AZT|500 ddC mg/kg.
Genetic Toxicology
- Micronucleus
(848765)
Completed
- Mice: B6C3F1
- Male Negative
- Micronucleus
(A72656)
Completed
- Mice: Swiss CD-1
- Male Positive
Organ Systems Toxicity
- 6 to 15 GD Conventional Teratology (Gavage)
(TER97001)
Completed
- Female Mice: Swiss CD-1
- Dose: AZT -- 0, 100, 200, OR 400 MG/KG/DAY AND DDC -- 0, 200, OR 500 MG/KG/DAY.
- 1 to 31 Repro/Dev Gen Tox (28-Day) (Gavage)
(RACB93149)
Completed
- Male and Female Mice: Swiss
- Dose: N/A; N/A; N/A; N/A.